Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Lyra Therapeutics ( (LYRA) ) just unveiled an update.
Lyra Therapeutics announced changes to its Board of Directors with the resignations of Michael Altman and Konstantin Poukalov. To maintain an equal balance among board classes, Maria Palasis, Ph.D. shifted from Class III to Class I, resulting in her resignation and immediate re-election, ensuring her service remained uninterrupted.
More about Lyra Therapeutics
YTD Price Performance: -96.15%
Average Trading Volume: 1,583,200
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $13.22M
For an in-depth examination of LYRA stock, go to TipRanks’ Stock Analysis page.
